Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XNCR Xencor Inc

交易中 03-02 13:51:34 EST

12.12

-0.65

-5.09%

最高13.30	最低11.85	成交量36.71万
今开12.26	昨收12.77	日振幅11.34%
总市值8.89亿	流通市值7.81亿	总股本7,334万
成交额446.16万	换手率0.57%	流通股本6,445万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XNCR","market":"US","secType":"STK","nameCN":"Xencor Inc","latestPrice":12.12,"timestamp":1772477490442,"preClose":12.77,"halted":0,"volume":367087,"delay":0,"changeRate":-0.05090054815974944,"floatShares":64446027,"shares":73338642,"eps":-1.24,"marketStatus":"交易中","change":-0.65,"latestTime":"03-02 13:51:34 EST","open":12.26,"high":13.2982,"low":11.85,"amount":4461640.372399,"amplitude":0.113406,"askPrice":12.19,"askSize":110,"bidPrice":12.11,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-1.24,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772485200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1386046800000,"exchange":"NASDAQ","adjPreClose":12.77,"preHourTrading":{"tag":"盘前","latestPrice":12.4,"preClose":12.77,"latestTime":"09:29 EST","volume":9314,"amount":117287.541598,"timestamp":1772461799999,"change":-0.37,"changeRate":-0.028974,"amplitude":0.152702},"postHourTrading":{"tag":"盘后","latestPrice":12.77,"preClose":12.77,"latestTime":"18:56 EST","volume":67236,"amount":858609.5451,"timestamp":1772236575479,"change":0,"changeRate":0,"amplitude":0.000783},"volumeRatio":0.661511,"impliedVol":0.3753,"impliedVolPercentile":0.251},"requestUrl":"/m/hq/s/XNCR","defaultTab":"news","newsList":[{"id":"2614502639","title":"Xencor, Inc.盘中异动 早盘股价大涨5.13%报12.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614502639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614502639?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:48","pubTimestamp":1772117337,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时48分，Xencor, Inc.股票出现异动，股价快速上涨5.13%。截至发稿，该股报12.60美元/股，成交量5.7334万股，换手率0.08%，振幅3.51%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.69%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022622485795422321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022622485795422321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"1117012994","title":"Xencor公司预计2026年末现金达4亿至4.3亿美元，资金可支撑运营至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1117012994","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117012994?lang=zh_cn&edition=full","pubTime":"2026-02-26 06:56","pubTimestamp":1772060170,"startTime":"0","endTime":"0","summary":"Xencor公司近日更新其财务预测，宣布到2026年末，公司现金储备预计将达到4亿至4.3亿美元。这一充足的资金规模将有力支持其运营活动持续至2028年。\n此次修正后的预测凸显了Xencor稳健的财务状况和长期发展规划。公司管理层表示，现有资金足以覆盖未来数年的研发投入及日常运营需求，为持续创新提供了坚实保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"1161361043","title":"Xencor Inc 2025年第四季度末未经审计现金及等价物与可售债务证券预计达6.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161361043","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161361043?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:09","pubTimestamp":1767877756,"startTime":"0","endTime":"0","summary":"Xencor Inc（股票代码：XNCR）宣布，在截至2025年12月31日的第四季度末，公司未经审计的现金、现金等价物及可售债务证券总额预计约为6.11亿美元。这一财务数据彰显了公司稳健的资金状况，为其后续的研发投入和业务拓展提供了充足的流动性支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"1119554184","title":"Xencor Inc预计现金储备足以支撑研发项目及运营至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1119554184","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119554184?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:08","pubTimestamp":1767877700,"startTime":"0","endTime":"0","summary":"Xencor Inc宣布，公司当前资金状况稳健，预计现有现金资源将能够持续支持其研发管线推进及日常运营至2028年末。这一预测基于对现有资金规模、研发支出节奏和业务拓展计划的综合评估，凸显了企业在中长期发展中的财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2586496674","title":"Xencor, Inc.盘中异动 早盘快速拉升5.04%报16.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586496674?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:48","pubTimestamp":1763995695,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时48分，Xencor, Inc.股票出现异动，股价大幅上涨5.04%。截至发稿，该股报16.67美元/股，成交量7.1489万股，换手率0.10%，振幅4.06%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224815a4b75a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224815a4b75a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139","KTTA"],"gpt_icon":0},{"id":"2578529100","title":"Xencor, Inc.盘中异动 临近午盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578529100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578529100?lang=zh_cn&edition=full","pubTime":"2025-10-24 23:33","pubTimestamp":1761319989,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日23时33分，Xencor, Inc.股票出现异动，股价大幅上涨5.11%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Theriva Biologics, Inc.、Genenta Science Spa、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为3108.56%、2328.64%、1872.02%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024233309a6cc5c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024233309a6cc5c10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2574192566","title":"Xencor, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574192566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574192566?lang=zh_cn&edition=full","pubTime":"2025-10-10 03:47","pubTimestamp":1760039245,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日03时47分，Xencor, Inc.股票出现异动，股价急速上涨5.00%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Galecto, Inc.、Biodexa Pharmaceuticals Plc、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1796.89%、1073.39%、991.62%，振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为261.20%、47.42%、42.25%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101003472594c0d74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101003472594c0d74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2573987931","title":"Xencor, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573987931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573987931?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:49","pubTimestamp":1759758583,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时49分，Xencor, Inc.股票出现波动，股价大幅上涨5.06%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Moolec Science Sa C/Wts 涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为2630.46%、118.26%、45.05%，振幅较大的相关个股有Spruce Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Leap Therapeutics, Inc.，振幅分别为164.63%、28.44%、27.33%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100621494394bcde22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100621494394bcde22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139","XNCR"],"gpt_icon":0},{"id":"2570885444","title":"Xencor, Inc.盘中异动 早盘大幅拉升5.03%报10.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570885444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570885444?lang=zh_cn&edition=full","pubTime":"2025-09-26 22:47","pubTimestamp":1758898028,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日22时47分，Xencor, Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报10.85美元/股，成交量13.282万股，换手率0.19%，振幅4.36%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092622470895472599&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092622470895472599&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2568282242","title":"Xencor, Inc.盘中异动 早盘股价大涨5.08%报9.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568282242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568282242?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:44","pubTimestamp":1758203042,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时44分，Xencor, Inc.股票出现波动，股价急速上涨5.08%。截至发稿，该股报9.72美元/股，成交量4.2691万股，换手率0.06%，振幅2.92%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214402a72877ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214402a72877ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2517430772","title":"Xencor, Inc.2024财年实现净利润-2.33亿美元，同比减少75.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430772","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430772?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363251,"startTime":"0","endTime":"0","summary":"3月8日，Xencor, Inc.公布财报，公告显示公司2024财年净利润为-2.33亿美元，同比减少75.19%；其中营业收入为1.10亿美元，同比减少37.14%，每股基本收益为-3.58美元。从资产负债表来看，Xencor, Inc.总负债2.78亿美元，其中短期债务51.46百万美元，资产负债比为3.43，流动比率为0.07。机构评级：截至2025年3月8日，当前有10家机构对Xencor, Inc.目标价做出预测，其中目标均价为30.30美元，其中最低目标价为22.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR"],"gpt_icon":0},{"id":"2516634986","title":"Xencor, Inc.盘中异动 下午盘快速跳水5.05%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634986?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:29","pubTimestamp":1741033747,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时29分，Xencor, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报14.59美元/股，成交量37.7305万股，换手率0.54%，振幅5.63%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4611.46%、215.05%、186.61%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2516377311","title":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516377311","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516377311?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XNCR"],"gpt_icon":0},{"id":"2514385233","title":"Xencor, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385233?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:34","pubTimestamp":1740666888,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时34分，Xencor, Inc.股票出现波动，股价大幅拉升5.01%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为429.63%、92.78%、66.03%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.14%、15.14%、14.83%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"1168323239","title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","url":"https://stock-news.laohu8.com/highlight/detail?id=1168323239","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168323239?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:25","pubTimestamp":1740662707,"startTime":"0","endTime":"0","summary":"Xencor 报告的季度每股亏损为$，好于分析师预期的$，超出20.51%。相比去年同期销售额$50.97M，本季度销售额增长了3.59%。以上内容来自Benzinga Earnings专栏，原文如下：Xencor  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 20.51 percent. This is a 44.19 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $52.79 million which beat the analyst consensus estimate of $19.48 million by 171.05 percent. This is a 3.59 percent increase over sales of $50.97 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR"],"gpt_icon":0},{"id":"2506894173","title":"Xencor, Inc.盘中异动 股价大跌5.08%报19.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506894173?lang=zh_cn&edition=full","pubTime":"2025-01-25 03:09","pubTimestamp":1737745755,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日03时09分，Xencor, Inc.股票出现异动，股价急速下挫5.08%。截至发稿，该股报19.42美元/股，成交量14.6523万股，换手率0.21%，振幅5.13%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Neuphoria Therapeutics Inc.、Evaxion Biotech As、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4300.35%、2362.24%、1715.58%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As，振幅分别为261.67%、220.61%、137.09%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030916abb78b57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030916abb78b57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2505789468","title":"Xencor, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505789468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505789468?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:10","pubTimestamp":1737490210,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时10分，Xencor, Inc.股票出现异动，股价快速上涨5.15%。截至发稿，该股报20.23美元/股，成交量26.2472万股，换手率0.38%，振幅5.07%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1052.00%、526.21%、190.70%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为96.32%、69.49%、50.37%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041010abb38e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041010abb38e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2503251886","title":"Xencor, Inc.盘中异动 早盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503251886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503251886?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:23","pubTimestamp":1736954594,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时23分，Xencor, Inc.股票出现波动，股价急速上涨5.39%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为205.05%、141.51%、78.00%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、61.30%、54.40%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232314a2230ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232314a2230ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2503635701","title":"Xencor, Inc.盘中异动 下午盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503635701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503635701?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:05","pubTimestamp":1736885109,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时05分，Xencor, Inc.股票出现波动，股价大幅下挫5.13%。截至发稿，该股报19.22美元/股，成交量31.5518万股，换手率0.45%，振幅6.12%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040509a221fdb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040509a221fdb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2502062895","title":"Xencor, Inc.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502062895?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:03","pubTimestamp":1736521434,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时03分，Xencor, Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报22.25美元/股，成交量7.3492万股，换手率0.11%，振幅2.07%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1089.24%、314.58%、193.47%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为72.56%、41.78%、37.29%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035595ff758c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035595ff758c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xencor.com","stockEarnings":[{"period":"1week","weight":0.1192},{"period":"1month","weight":0.034},{"period":"3month","weight":-0.2627},{"period":"6month","weight":0.5707},{"period":"1year","weight":-0.1475},{"period":"ytd","weight":-0.1659}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xencor, Inc.在加利福尼亚州成立于1997年8月，2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司，专注于发现和开发工程化的单克隆抗体和细胞因子疗法，以治疗癌症和自身免疫性疾病患者，这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解，并设计新技术和具有改进特性的XmAb候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.230769,"avgChangeRate":-0.060713},{"month":2,"riseRate":0.615385,"avgChangeRate":0.046082},{"month":3,"riseRate":0.25,"avgChangeRate":-0.051542},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.037771},{"month":5,"riseRate":0.583333,"avgChangeRate":0.018254},{"month":6,"riseRate":0.583333,"avgChangeRate":0.087611},{"month":7,"riseRate":0.583333,"avgChangeRate":0.001228},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.015523},{"month":9,"riseRate":0.416667,"avgChangeRate":0.016645},{"month":10,"riseRate":0.5,"avgChangeRate":0.005748},{"month":11,"riseRate":0.916667,"avgChangeRate":0.149173},{"month":12,"riseRate":0.5,"avgChangeRate":0.005588}],"exchange":"NASDAQ","name":"Xencor Inc","nameEN":"Xencor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xencor Inc,XNCR,Xencor Inc股票,Xencor Inc股票老虎,Xencor Inc股票老虎国际,Xencor Inc行情,Xencor Inc股票行情,Xencor Inc股价,Xencor Inc股市,Xencor Inc股票价格,Xencor Inc股票交易,Xencor Inc股票购买,Xencor Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}